Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.

Antioxidants were administered to diabetic rats and experimentally galactosemic rats to evaluate the ability of these agents to inhibit the development of diabetic retinopathy. Alloxan diabetic rats and nondiabetic rats that were fed 30% galactose randomly received standard diets or the diets supplemented with ascorbic acid and alpha-tocopherol (vitamins C+E diet) or a more comprehensive mixture of antioxidants (multi-antioxidant diet), including Trolox, alpha-tocopherol, N-acetyl cysteine, ascorbic acid, beta-carotene, and selenium. Diabetes or galactose feeding of at least 12 months resulted in pericyte loss, acellular capillaries, and basement membrane thickening. Compared with diabetic controls, the development of acellular capillaries was inhibited by 50% (P < 0.05) in diabetic rats that received supplemental vitamins C+E, and the number of pericyte ghosts tended to be reduced. The vitamins C+E supplement had no beneficial effect in galactosemic rats, but these rats consumed only approximately half as much of the antioxidants as the diabetic rats. The multi-antioxidant diet significantly inhibited ( approximately 55-65%) formation of both pericyte ghosts and acellular capillaries in diabetic rats and galactosemic rats (P < 0.05 vs. controls), without affecting the severity of hyperglycemia. Parameters of retinal oxidative stress, protein kinase C activity, and nitric oxides remained elevated for at least 1 year of hyperglycemia, and these abnormalities were normalized by multi-antioxidant therapy. Thus, long-term administration of antioxidants can inhibit the development of the early stages of diabetic retinopathy, and the mechanism by which this action occurs warrants further investigation. Supplementation with antioxidants can offer an achievable and inexpensive adjunct therapy to help inhibit the development of retinopathy in diabetes.

[1]  T. Kern,et al.  Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. , 1999, Free radical biology & medicine.

[2]  D. Godin,et al.  Alterations in Free Radical Tissue-Defense Mechanisms in Streptozocin-Induced Diabetes in Rat: Effects of Insulin Treatment , 1987, Diabetes.

[3]  T. Kern,et al.  Experimental Galactosemia Produces Diabetic-like Retinopathy , 1984, Diabetes.

[4]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[5]  N. Laver,et al.  Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor. , 1990, Experimental eye research.

[6]  G. Romeo,et al.  Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. , 2000, Investigative ophthalmology & visual science.

[7]  G. Lutty,et al.  Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. , 1998, Free radical biology & medicine.

[8]  T. Kern,et al.  Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine , 2000, Current eye research.

[9]  Alan W. Stitt,et al.  Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. , 1997, The American journal of pathology.

[10]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[11]  A. Cerami,et al.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.

[12]  J. Witztum,et al.  Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. A. North,et al.  Multiple antioxidants protect against heme protein and lipid oxidation in kidney tissue. , 1996, Free radical biology & medicine.

[14]  D. Armstrong,et al.  Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests. , 1992, Journal of diabetes and its complications.

[15]  M. Mcdaniel,et al.  Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation , 1993, Diabetes.

[16]  W. Li,et al.  Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. , 1999, Cellular and molecular biology.

[17]  S. J. Chen,et al.  Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. , 1992, Biochemical and biophysical research communications.

[18]  N. Farid,et al.  Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. , 1998, Diabetes.

[19]  Y. Akagi,et al.  Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. , 1990, Archives of ophthalmology.

[20]  G. King,et al.  Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia , 1994, Diabetes.

[21]  G. King,et al.  Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus , 1997, Journal of Molecular Medicine.

[22]  T. Kern,et al.  Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. , 1994, Current eye research.

[23]  T. Kern,et al.  Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. , 1997, Free radical biology & medicine.

[24]  R. Unger,et al.  Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. , 1968, The Journal of clinical investigation.

[25]  A. Azzi,et al.  Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells. , 1994, European journal of biochemistry.

[26]  A. Mansour,et al.  Prevention of pericyte loss by trolox in diabetic rat retina. , 1998, Journal of toxicology and environmental health. Part A.

[27]  B. Reboussin,et al.  Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. , 1998, Ophthalmology.

[28]  T. Kern,et al.  Galactose-induced retinal microangiopathy in rats. , 1995, Investigative ophthalmology & visual science.

[29]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[30]  T. Kern,et al.  A mouse model of diabetic retinopathy. , 1996, Archives of ophthalmology.

[31]  B. Mayer,et al.  Inhibition of purified soluble guanylyl cyclase by L-ascorbic acid. , 2000, Cardiovascular research.

[32]  T. Kern,et al.  Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. , 1994, Investigative ophthalmology & visual science.

[33]  T. Kern,et al.  Diabetes-induced metabolic abnormalities in myocardium: Effect of antioxidant therapy , 2000, Free radical research.

[34]  W. Pryor Vitamin E and heart disease: basic science to clinical intervention trials. , 2000, Free radical biology & medicine.

[35]  K. H. Kim,et al.  High glucose can induce lipid peroxidation in the isolated rat glomeruli. , 1994, Kidney international.

[36]  T. Kern,et al.  Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.

[37]  H. Hammes,et al.  Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine , 1997, Diabetologia.

[38]  G. King,et al.  Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. , 1997, Journal of the American Society of Nephrology : JASN.

[39]  T. Kern,et al.  Retinal glutamate in diabetes and effect of antioxidants , 2001, Neurochemistry International.

[40]  T. Kern,et al.  Retinopathy in animal models of diabetes. , 1995, Diabetes/metabolism reviews.

[41]  R. Cohen,et al.  Free radicals mediate endothelial cell dysfunction caused by elevated glucose. , 1992, The American journal of physiology.